$175.38 -0.87 (%) C R Bard Inc - NYSE

Apr. 24, 2015 | 04:00 PM

Partner Headlines

  1. Earnings Scheduled For April 23, 2015

    Benzinga | Apr. 23, 2015 | 04:03AM EST
  2. 3 Stocks that Outperformed the Market by More than 40% During the Great Recession

    GuruFocus | Apr. 21, 2015 | 10:31AM EST
  3. Teleflex Declares Its Quarter Four Results

    GuruFocus | Feb. 24, 2015 | 11:49AM EST
  4. Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4

    Benzinga | Feb. 13, 2015 | 14:19PM EST
  5. JMP Securities Covers Mostly Good News From Pharma Pending More Visibility

    Benzinga | Feb. 11, 2015 | 07:54AM EST
  6. Nuveen's Bob Doll Runs Several Top Funds

    IBD | Feb. 3, 2015 | 18:22PM EST
  7. Earnings Scheduled For January 29, 2015

    Benzinga | Jan. 29, 2015 | 04:45AM EST
  8. Morgan Stanley Issues Wave Of Pharma & Medical Device Upgrades, Downgrades

    Benzinga | Jan. 5, 2015 | 15:57PM EST
  9. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus | Nov. 19, 2014 | 12:37PM EST
  10. Weekly 52-Week Highs Highlight: LBTYK, STZ, FISV, BCR

    GuruFocus | Nov. 9, 2014 | 01:57AM EST
  11. Earnings Scheduled For October 22, 2014

    Benzinga | Oct. 22, 2014 | 05:16AM EST
  12. Dividend Aristocrats In Focus Part 19 of 54: CR Bard

    GuruFocus | Oct. 15, 2014 | 12:45PM EST
  13. The Lutonix® 035 Drug Coated Balloon Is The First And Only FDA-Approved DCB Available In The U.S. For The Treatment Of Femoropopliteal Occlusive Disease

    Benzinga | Oct. 10, 2014 | 09:27AM EST
  14. UPDATE: Bank Of America Downgrades C.R. Bard

    Benzinga | Jul. 30, 2014 | 09:03AM EST
  15. Earnings Scheduled For July 24, 2014

    Benzinga | Jul. 24, 2014 | 05:31AM EST
  16. UPDATE: S&P Capital Downgrades C.R. Bard On Revised 2014 EPS Estimate

    Benzinga | Jun. 20, 2014 | 10:12AM EST
  17. Headwinds For C.R. Bard, According To Barclays

    Benzinga | Jun. 18, 2014 | 10:54AM EST
  18. Benzinga's Top Downgrades

    Benzinga | Jun. 18, 2014 | 07:56AM EST
  19. Morgan Stanley Remains Concerned About C.R. Bard

    Benzinga | Jun. 13, 2014 | 08:50AM EST
  20. Stocks To Watch For June 12, 2014

    Benzinga | Jun. 12, 2014 | 04:19AM EST
  21. Becton, Dickinson and Co. (BDX) Dividend Stock Analysis

    GuruFocus | May. 30, 2014 | 12:32PM EST
  22. Morgan Stanley Still Sees Acceleration Risk for C.R. Bard

    Benzinga | Apr. 23, 2014 | 10:28AM EST
  23. Earnings Scheduled For April 22, 2014

    Benzinga | Apr. 22, 2014 | 05:14AM EST
  24. UPDATE: Bank of America Downgrades C.R. Bard on Multiple Factors

    Benzinga | Apr. 8, 2014 | 08:56AM EST
  25. Yacktman Funds Comments on C.R. Bard Inc.

    GuruFocus | Mar. 12, 2014 | 10:51AM EST
  26. Bard Announces $500M Share Repurchase Authorization

    Benzinga | Jan. 30, 2014 | 16:09PM EST
  27. Yacktman Fund Comments on C.R. Bard Inc.

    GuruFocus | Jan. 30, 2014 | 12:06PM EST
  28. Earnings Scheduled For January 30, 2014

    Benzinga | Jan. 30, 2014 | 04:54AM EST
  29. Risk and Cycles: Looking at Buybacks, Debt, Cash

    YCharts | Jan. 28, 2014 | 18:01PM EST
  30. Weekly Insider Sells Highlight: BCR, GLUU, AMT, APOL, JACK

    GuruFocus | Jan. 20, 2014 | 10:56AM EST
  31. Anti-Elitism: Beating The Dividend Aristocrats

    YCharts | Dec. 12, 2013 | 16:32PM EST
  32. UPDATE: Goldman Sachs Upgrades C.R. Bard as Elements Driving Sell Thesis are Resolved

    Benzinga | Oct. 23, 2013 | 10:09AM EST
  33. UPDATE: Piper Jaffray Upgrades C.R. Bard on Improving Organic Growth Profile, PVD Market Exposure

    Benzinga | Oct. 23, 2013 | 10:07AM EST
  34. Benzinga's Top Upgrades

    Benzinga | Oct. 23, 2013 | 07:49AM EST
  35. C.R. Bard Rises After Q3 Earnings Beat (BCR)

    Benzinga | Oct. 22, 2013 | 16:27PM EST
  36. Earnings Scheduled For October 22, 2013

    Benzinga | Oct. 22, 2013 | 04:49AM EST
  37. UPDATE: Citigroup Raises PT on C.R. Bard on Adjusted BCR Estimates

    Benzinga | Oct. 14, 2013 | 11:47AM EST
  38. CryoLife Says Will Receive ~$15.1M Related to Purchase of Medafor by CR Bard

    Benzinga | Oct. 7, 2013 | 08:37AM EST
  39. Market Wrap For Wednesday, September 4: Markets Increase Slightly As M&As Continue To Rise

    Benzinga | Sep. 4, 2013 | 18:33PM EST
  40. Benzinga's M&A Chatter for Wednesday September 4, 2013

    Benzinga | Sep. 4, 2013 | 17:52PM EST
  41. Morning Market Movers

    Benzinga | Sep. 4, 2013 | 10:00AM EST
  42. Benzinga's Top Pre-Market Gainers

    Benzinga | Sep. 4, 2013 | 08:07AM EST
  43. UPDATE: Bard to Purchase Rochester Medical at $20/Share, or ~$262M Deal

    Benzinga | Sep. 4, 2013 | 07:10AM EST
  44. UPDATE: Bank of America Raises PT on C.R. Bard Following CEO/CFO Meetings

    Benzinga | Aug. 29, 2013 | 11:30AM EST
  45. St. Jude acquires new tech

    IBD | Aug. 19, 2013 | 18:48PM EST
  46. St. Jude, C.R. Bard Make Medical Device Acquisitions

    IBD | Aug. 19, 2013 | 12:06PM EST
  47. CR Bard Announces Deal to Buy Medafor for $200M; Sees Deal Dilutive to Adj. EPS in FY13, Neutral in FY14

    Benzinga | Aug. 19, 2013 | 08:03AM EST
  48. UPDATE: Citigroup Reiterates Neutral Rating, Lowers PT on C.R. Bard

    Benzinga | Feb. 1, 2013 | 07:38AM EST
  49. UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Lowers PT on C.R. Bard

    Benzinga | Feb. 1, 2013 | 03:22AM EST
  50. UPDATE: C.R. Bard Q4 Profit Rises 13%

    Benzinga | Jan. 31, 2013 | 21:10PM EST
Trading Center